Share on LinkedInShare on LinkedIn

ARTICLE · 29 JANUARY 2019

Re China Biologic – Shareholder Standing

Walkers
Walkers
Contributor
Walkers

Walkers

Firm Details Global Managing Partner: Ingrid Pierce Office Managing Partner: Daniel Wood Number of...

View firm profile
Explore more from Walkers

A recent judgment in the matter of David Gao v China Biologic Products Holdings, Inc, has provided guidance regarding the standing of shareholders to commence certain proceedings against Cayman Islands companies.

Cayman IslandsCorporate/Commercial Law

A recent judgment in the matter of David (Xiaoying) Gao v China Biologic Products Holdings, Inc, has provided guidance regarding the standing of shareholders to commence certain proceedings against Cayman Islands companies.

Mr Gao - a beneficial (but not registered) shareholder and the former Chairman and CEO of China Biologic Products Holdings, Inc. - commenced proceedings against the company alleging inter alia that the directors of the company had, in breach of their duties, caused it to improperly issue certain shares. In response, the company applied to strike out the proceedings on bases including that Mr Gao lacked standing (i.e. sufficient proximity to the subject of the complaint).

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from